Albertsons Boosts Dividend Despite Failed Merger and Opioid Liabilities: Is It Safe?

By Trey Thoelcke Published Apr 16, 11:30AM EDT

Quick Read

Albertsons Companies (ACI) has raised its quarterly dividend 13%. Income investors want to know whether that yield is a reward or a warning sign.
Free cash flow covers the dividend, and operating cash flow is substantial. However, coverage is declining.
The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE.

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Albertsons Boosts Dividend Despite Failed Merger and Opioid Liabilities: Is It Safe? — © travenian / Getty Images

Albertsons Companies (NYSE: ACI) operates 2,244 supermarkets under banners including Albertsons, Safeway, Vons, and Jewel-Osco. The company has raised its quarterly dividend 13% to $0.17 per share, bringing the annualized payout to $0.68 per share. At a stock price of $16.50, the yield sits near 4%. The question income investors should ask is whether that yield is a reward or a warning sign.

Metric	Value
Annual Dividend	$0.68 per share
Dividend Yield	~4%
Most Recent Increase	13% (April 2026)
Dividend Aristocrat/King	No
Dividend Initiated	2020 (post-IPO)

FCF Coverage Is Thin and Getting Thinner

Free cash flow is the core concern. Albertsons generated $527.3 million in FCF in FY2026 against $322.7 million in dividends paid, producing coverage of 1.63x. That is down sharply from 2.54x in FY2025 and 2.27x in FY2024. FCF itself fell 29.64% year over year.

Metric	TTM Value	Assessment
Earnings Payout Ratio (Adjusted EPS $2.18, Div $0.60)	$0.60 div ÷ $2.18 EPS	Healthy on adjusted basis
FCF Payout Ratio	$322.7M / $527.3M FCF	Elevated
FCF Coverage	1.63x	Thinning
Operating Cash Flow Coverage	$2.37B OCF vs $322.7M dividends	Strong

FY2026 capital expenditure guidance of $2.0 billion to $2.2 billion against operating cash flow similar to recent $2.37 billion means FCF could compress further, leaving minimal headroom for the dividend after capital spending.

Leverage Adds Real Risk to the Dividend

The balance sheet is uncomfortable. Shareholders’ equity collapsed 45.77% to $1.836 billion, driven largely by a $773.8 million opioid settlement charge. Long-term debt rose to $8.41 billion, and the current ratio sits at roughly 0.86x, below the 1.0 threshold signaling liquidity stress. Cash on hand is $198.6 million.

Metric	Value	Assessment
Net Debt-to-EBITDA	2.24x (up from 1.88x)	Manageable but rising
Long-Term Debt	$8.41B	Elevated
Cash on Hand	$198.6M	Thin
Current Ratio	~0.86x	Below comfort threshold

Opioid settlement payments spread over nine years represent a known drain. The failed Kroger merger left ongoing litigation costs and strategic uncertainty without synergies that would have strengthened the balance sheet.

Management Signals Confidence, but Watch Capex

CEO Susan Morris said on the Q4 FY2026 earnings call: “As we enter fiscal 2026, we are building on this foundation by scaling our productivity engine and positioning the company to deliver earnings growth, strong cash flow, and long-term shareholder returns.” The board reinforced confidence by increasing the share repurchase authorization to $2.0 billion on April 14, 2026.

FY2026 adjusted EPS guidance of $2.22 to $2.32 and adjusted EBITDA of $3.85 billion to $3.925 billion are constructive. But a 150-basis-point headwind from IRA Medicare drug pricing will pressure identical sales, guided to just 0.0% to 1.0% growth. Pharmacy has driven Albertsons’ comparable sales, so this headwind matters.

Moderate Risk: The Dividend Survives, but the Margin Is Narrow

Dividend Safety Rating: Moderate Risk

FCF covers the dividend at 1.63x, and operating cash flow is substantial. However, coverage is declining, capex is rising, the balance sheet is thin, and the opioid charge wiped out most equity cushion. Albertsons is a leveraged grocer managing real liabilities in a competitive, low-margin industry.

FCF stabilizing above $500 million and a transitory pharmacy headwind would support the dividend. If capex guidance pushes FCF below the dividend line or opioid settlement payments accelerate, the safety margin narrows further. The 4% yield carries risk.

About the Author Trey Thoelcke →

Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.

Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.

Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.

Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.